Nova Patents
AT347595T

Human vascular endothelial growth factor 2

Abstract

The invention claims a human VEGF2 polypeptide and codes the polypeptide VEGF2 DNA (RNA), and method for producing the polypeptide through the recombination technology method and process of the polypeptide antibody and antagonist. The invention further claims for the method according to any one of the polypeptide stimulation receptor-1 and/or and blood vessel tissue repair. The antagonist is the invention also claimed in one of the following tumour growth and inflammation and treatment of noise-induced, the rheumatic arthritis psoriasis's and method. The invention further claims for detecting mutation and VEGF2 the protein concentration VEGF2 coding sequence diagnostic method for changing from host's sample.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

80 members in 14 offices

This recordMember, by publication datePriority claim4 more offices are in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
46596895United States of AmericaA

Members80

Family members, oldest first
DocumentOfficeKind
CA2184584A1CanadaA1
CA2414016A1CanadaA1
WO9524473A1World Intellectual Property Organization (WIPO)A1
AU696764CAustraliaC
AU7394194AAustraliaA
ZA943464BSouth AfricaB
CA2224093A1CanadaA1
CA2413012A1CanadaA1
WO9639515A1World Intellectual Property Organization (WIPO)A1
AU6046796AAustraliaA
EP0751992A1European Patent Office (EPO)A1
CN1145636AChinaA
JPH09510093AJapanA
EP0751992A4European Patent Office (EPO)A4
MX9709243AMexicoA
EP0837934A1European Patent Office (EPO)A1
CN1186518AChinaA
AU696764B2AustraliaB2
KR19990022522ARepublic of KoreaA
US5932540AUnited States of AmericaA
US5935820AUnited States of AmericaA
CA2322748A1CanadaA1
WO9946364A1World Intellectual Property Organization (WIPO)A1
AU3072099AAustraliaA
WO9946364A9World Intellectual Property Organization (WIPO)A9
JPH11513883AJapanA
AU714484B2AustraliaB2
JP2000069982AJapanA
US6040157AUnited States of AmericaA
EP0837934A4European Patent Office (EPO)A4
EP1062319A1European Patent Office (EPO)A1
KR20010034576ARepublic of KoreaA
CN1299407AChinaA
JP2002505873AJapanA
US2002120123A1United States of AmericaA1
US2002182683A1United States of AmericaA1
US2003008357A1United States of AmericaA1
US2003028007A1United States of AmericaA1
CA2224093CCanadaC
CA2184584CCanadaC
EP1062319A4European Patent Office (EPO)A4
US6608182B1United States of AmericaB1
JP2004000267AJapanA
US6734285B2United States of AmericaB2
US2004143103A1United States of AmericaA1
US2004214286A1United States of AmericaA1
CN1552855AChinaA
US2005176103A1United States of AmericaA1
EP0751992B1European Patent Office (EPO)B1
AT309360TAustriaT
ATE309360T1AustriaT1
US2005256050A1United States of AmericaA1
DE69434538D1GermanyD1
KR100511692B1Republic of KoreaB1
US2005287143A1United States of AmericaA1
US2006025331A1United States of AmericaA1
DK0751992T3DenmarkT3
ES2249762T3SpainT3
CN1267550CChinaC
DE69434538T2GermanyT2
JP2006238893AJapanA
US7109308B1United States of AmericaB1
US7115392B2United States of AmericaB2
EP0837934B1European Patent Office (EPO)B1
JP2006333865AJapanA
AT347595TThis recordAustriaT
ATE347595T1AustriaT1
US7153827B1United States of AmericaB1
US7153942B2United States of AmericaB2
DE69636752D1GermanyD1
US7186688B1United States of AmericaB1
US7227005B1United States of AmericaB1
JP2007244388AJapanA
DE69636752T2GermanyT2
US7439333B2United States of AmericaB2
US7498417B2United States of AmericaB2
US2009192088A1United States of AmericaA1
US7576189B2United States of AmericaB2
JP4439490B2JapanB2
US2010143360A1United States of AmericaA1